Thermo Fisher Scientific | Pasivo Circulante



Current Liabilities Cambio Fecha
Abbott USD 13B 1.15B 2025-03
Agilent USD 1.87B 26M 2025-01
Becton, Dickinson and Co. USD 7.69B 27M 2025-03
Bio Techne USD 169.2M 7.95M 2025-03
Bio-Rad Laboratories USD 506.6M 38.8M 2025-03
Boston Scientific USD 5.06B 1.34B 2025-03
Bruker USD 1.34B 60.3M 2025-03
Charles River Laboratories USD 1.05B 56.95M 2025-03
Danaher USD 6.64B 153M 2025-03
Dentsply International USD 1.59B 47M 2024-12
Edwards Lifesciences USD 1.51B 438.9M 2024-12
Exact Sciences USD 502.46M 229.72M 2025-03
General Electric USD 34.94B 549M 2025-03
Henry Schein USD 2.8B 126M 2024-12
Hologic USD 989.7M 12.7M 2025-03
Illumina USD 1.55B 572M 2024-12
Intuitive Surgical USD 2.01B 200.9M 2025-03
IQVIA Holdings USD 7.18B 222M 2025-03
Laboratory Of America USD 2.06B 1.27B 2025-03
Medtronic USD 11.84B 355M 2025-01
Mettler Toledo International USD 1.15B 18.5M 2025-03
Myriad Genetics USD 151.1M 13M 2025-03
Olympus JPY 414.56B 5.02B 2024-12
Quest Diagnostics USD 1.44B 728M 2025-03
Repligen USD 152M 25.21M 2025-03
Revvity USD 648.19M 4.91M 2025-03
Stryker USD 7.93B 313M 2025-03
Thermo Fisher Scientific USD 13.17B 158M 2025-03
Veracyte USD 78.63M 8.32M 2024-12
Waters USD 960.97M 171.21M 2025-03
Zimmer Biomet Holdings USD 2.45B 1.12B 2024-12



Thermo Fisher Scientific Pasivo Circulante - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - May 2025.